Ledaga (chlormethine hydrochloride)

pCPA File Number: 21677

Negotiation Status:

Concluded without agreement

Indication(s):

For the treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL)

Sponsor/Manufacturer:

Recordati Rare Diseases Canada Inc.

CADTH Project Number:

PC0242

pCPA Engagement Letter Issued:

2022-10-21

Negotiation Process Concluded:

2023-01-27